ConforMIS Inc (NASDAQ:CFMS) Hit With “Buy” Rating From Sterne Agee CRT, Analysts Expect $26.00 Stock Price


Why Has Sterne Agee CRT Given ConforMIS Inc (NASDAQ:CFMS) a $26.00 Price Target

New York: ConforMIS Inc (NASDAQ:CFMS) coverage was started with a key ‘”Buy”‘ rating as well as a $26.00 target price per share at Sterne Agee CRT. The TP by Sterne Agee CRT means upside of 18.99% from the current stock price.

From a total of 4 analysts covering ConforMIS Inc (NASDAQ:CFMS) stock, 5 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that 100% of the ratings are positive. The highest target price is $26 while the lowest target price is $22. The mean of all analyst targets is $24 with a 24.89% above today’s ($21.82) stock price. ConforMIS Inc was the topic of 6 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. Oppenheimer maintained shares on August 12 with “Outperform” rating. JP Morgan initiated CFMS stock in a recent report from July 27 with “Overweight” rating. Finally, Canaccord Genuity initiated the stock with “Buy” rating in a report issued on a July 27.

Approximately 30,484 shares of stock traded hands. ConforMIS Inc (NASDAQ:CFMS) has risen 6.00% since November 1, 2015 and is uptrending. It has outperformed by 7.62% the S&P500.

ConforMIS Inc (NASDAQ:CFMS) Hit With

ConforMIS, Inc. is a medical technology company. The company has a market cap of $879.18 million. The Firm uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, to fit each patient’s anatomy. It currently has negative earnings. It is engaged in offering a line of customized knee implants designed to restore the natural shape of a patient’s knee.

According to Zacks Investment Research, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company’s iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. ConforMIS, Inc. is based in Bedford, United States.” Get a free copy of the Zacks research report on ConforMIS Inc (CFMS)